524689 Stock Overview
Parenteral Drugs (India) Limited operates as a healthcare company in India.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Parenteral Drugs (India) Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹3.39 |
52 Week High | ₹5.11 |
52 Week Low | ₹3.08 |
Beta | 0 |
11 Month Change | 0% |
3 Month Change | 4.63% |
1 Year Change | -33.66% |
33 Year Change | n/a |
5 Year Change | -63.90% |
Change since IPO | 5.73% |
Recent News & Updates
Recent updates
Shareholder Returns
524689 | IN Pharmaceuticals | IN Market | |
---|---|---|---|
7D | 0% | -1.5% | -0.8% |
1Y | -33.7% | 50.3% | 34.7% |
Return vs Industry: 524689 underperformed the Indian Pharmaceuticals industry which returned 30.4% over the past year.
Return vs Market: 524689 underperformed the Indian Market which returned 19.1% over the past year.
Price Volatility
524689 volatility | |
---|---|
524689 Average Weekly Movement | n/a |
Pharmaceuticals Industry Average Movement | 6.3% |
Market Average Movement | 6.2% |
10% most volatile stocks in IN Market | 9.2% |
10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 524689 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 524689's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1983 | n/a | n/a | www.pdindia.com |
Parenteral Drugs (India) Limited operates as a healthcare company in India. The company manufactures pharmaceutical products, including intravenous infusion, inhalation, veterinary infusion, etc. It also offers IV fluids, such as carbohydrates and electrolytes, diuretics, dialysis and irrigation solutions, anti-infective and anti-fungal products, and others; and oncology and anaesthesia products. The company also exports its products to Iraq, Yemen, Mozambique, Ghana, Kenya, Kyrgyzstan, Uzbekistan, Sudan, Vietnam, Cambodia, Liberia, Sri Lanka, Nepal, Myanmar, and Cameroon.
Parenteral Drugs (India) Limited Fundamentals Summary
524689 fundamental statistics | |
---|---|
Market cap | ₹101.08m |
Earnings (TTM) | -₹763.62m |
Revenue (TTM) | ₹84.96m |
0.0x
P/S Ratio0.0x
P/E RatioIs 524689 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
524689 income statement (TTM) | |
---|---|
Revenue | ₹84.96m |
Cost of Revenue | ₹54.66m |
Gross Profit | ₹30.31m |
Other Expenses | ₹793.93m |
Earnings | -₹763.62m |
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did 524689 perform over the long term?
See historical performance and comparison